The Cigna Group (CI) Stock: Buy, Sell, or Hold?
CI - The Cigna Group
$315.88
11.51 (3.78%)
▲
5d:
+5.71%
30d:
+17.75%
90d:
+9.09%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When CI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CI shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$396.05
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$245.92
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CI is currently trading at $315.88, which is considered extended relative to its 30-day fair value range of $269.72 to $291.15. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.4) compared to its historical average (8.5). At these levels, the market is pricing in 3.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CI is in a downtrend. The price is approaching resistance at $316.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: CI scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CI is in a downtrend. The price is approaching resistance at $316.26. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: CI scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$269.72 -
$291.15
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
Protect Your Profits
CI is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.5% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- NEUTRAL: Near Wall St target ($342.29)
- NEUTRAL: Market pricing in 3.4% annual earnings growth - fairly valued
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$269.72 -
$291.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$277.43
Resistance Level
$316.27
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.43
Wall Street Target
$342.29
(+8.4%)
Revenue Growth (YoY)
6.7%
Earnings Growth (YoY)
10.2%
Profit Margin
2.3%
Valuation Premium vs History
+3.4% premium
PE vs Historical
9.4 vs 8.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.4%
(market-implied from PE analysis)
1-Year Target
$326.62
(+3%)
2-Year Target
$337.72
(+7%)
3-Year Target
$349.21
(+11%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$314.65
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 9.7%)
$879.07
(+178%)
Base:
(SPY PE: 9.4, Growth: 9.7%)
$417.56
(+32%)
Bear:
(PE: 8.0, Growth: 9.7%)
$354.93
(+12%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 12.67 | Current EPS (TTM): $24.19
Bull Case
$466.85
(+53%)
Analyst growth 38.4%, PE expands to 13.9
Base Case
$424.41
(+39%)
Market implied 38.4%, PE stable at 12.7
Bear Case
$208.49
(-32%)
Severe decline -20.0%, PE contracts to 10.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 5:30 PM ET
Data refreshes hourly during market hours. Next update: 6:30 PM
Data refreshes hourly during market hours. Next update: 6:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 39 SELL |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
26 analysts |
$477 | 29 SELL |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 37 SELL |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$452 | 31 SELL |
|
ALHC
Alignment Healthcare LLC |
STRONG BUY
14 analysts |
$13 | 52 HOLD |
Advanced CI Option Strategies
Professional options setups generated by AI based on today's CI price and gamma walls.
